Myolex
Brookline, US · 1 known investors
Myolex develops a portable, non-invasive electrical impedance myography (EIM) device that measures muscle composition and structure to assist in the diagnosis and monitoring of neuromuscular disorders and muscle wasting diseases. The device is designed for clinical research and at-home use by patients, clinicians, and caregivers.
Investors · 1
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2012 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $289.9K |
| National Science Foundation | Phase I | 2011 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $220.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.